CNSX:SNN

Smith & Nephew Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume44,398 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Smith & Nephew (CNSX:SNN) Vs. VMD, TMD, HTL, PTQ, PHM, and HSM

Should you be buying SNN stock or one of its competitors? Companies in the industry of "medical devices" are considered alternatives and competitors to Smith & Nephew, including Viemed Healthcare (VMD), Titan Medical (TMD), Hamilton Thorne (HTL), Protech Home Medical (PTQ), Protech Home Medical (PHM), and Helius Medical Technologies (HSM).

Viemed Healthcare (TSE:VMD) and Smith & Nephew (CNSX:SNN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Analyst Recommendations

This is a summary of current recommendations and price targets for Viemed Healthcare and Smith & Nephew, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Viemed Healthcare01002.00
Smith & Nephew0000N/A

Earnings and Valuation

This table compares Viemed Healthcare and Smith & Nephew's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viemed HealthcareC$131.31 million3.53$38.61 millionC$0.9812.02
Smith & NephewN/AN/AN/AN/AN/A

Viemed Healthcare has higher revenue and earnings than Smith & Nephew.

Profitability

This table compares Viemed Healthcare and Smith & Nephew's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Viemed HealthcareN/AN/AN/A
Smith & NephewN/AN/AN/A

Summary

Viemed Healthcare beats Smith & Nephew on 1 of the 1 factors compared between the two stocks.

Smith & Nephew (CNSX:SNN) and Titan Medical (TSE:TMD) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of current recommendations for Smith & Nephew and Titan Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Smith & Nephew0000N/A
Titan Medical00103.00

Profitability

This table compares Smith & Nephew and Titan Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Smith & NephewN/AN/AN/A
Titan MedicalN/AN/AN/A

Earnings and Valuation

This table compares Smith & Nephew and Titan Medical's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith & NephewN/AN/AN/AN/AN/A
Titan MedicalC$20 million10.84C$-49,505,300.00C($0.45)-4.38

Smith & Nephew has higher earnings, but lower revenue than Titan Medical.

Summary

Titan Medical beats Smith & Nephew on 2 of the 2 factors compared between the two stocks.

Smith & Nephew (CNSX:SNN) and Hamilton Thorne (CVE:HTL) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations.

Earnings and Valuation

This table compares Smith & Nephew and Hamilton Thorne's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith & NephewN/AN/AN/AN/AN/A
Hamilton ThorneC$39.78 million6.08C$1.25 millionC$0.01193.33

Hamilton Thorne has higher revenue and earnings than Smith & Nephew.

Profitability

This table compares Smith & Nephew and Hamilton Thorne's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Smith & NephewN/AN/AN/A
Hamilton ThorneN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings for Smith & Nephew and Hamilton Thorne, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Smith & Nephew0000N/A
Hamilton Thorne00403.00

Hamilton Thorne has a consensus price target of C$1.87, indicating a potential upside of 7.47%.

Summary

Hamilton Thorne beats Smith & Nephew on 2 of the 2 factors compared between the two stocks.

Protech Home Medical (CVE:PTQ) and Smith & Nephew (CNSX:SNN) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Protech Home Medical and Smith & Nephew, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Protech Home Medical00503.00
Smith & Nephew0000N/A

Protech Home Medical presently has a consensus price target of C$2.58, suggesting a potential upside of 20.16%.

Profitability

This table compares Protech Home Medical and Smith & Nephew's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Protech Home MedicalN/AN/AN/A
Smith & NephewN/AN/AN/A

Valuation and Earnings

This table compares Protech Home Medical and Smith & Nephew's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protech Home MedicalC$82.22 million2.95$-5,417,568.00C($0.05)-44.79
Smith & NephewN/AN/AN/AN/AN/A

Smith & Nephew has lower revenue, but higher earnings than Protech Home Medical.

Summary

Protech Home Medical beats Smith & Nephew on 2 of the 2 factors compared between the two stocks.

Protech Home Medical (CVE:PHM) and Smith & Nephew (CNSX:SNN) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Earnings & Valuation

This table compares Protech Home Medical and Smith & Nephew's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protech Home MedicalC$77.14 million0.62$833,022.00C$0.0057.50
Smith & NephewN/AN/AN/AN/AN/A

Protech Home Medical has higher revenue and earnings than Smith & Nephew.

Analyst Recommendations

This is a breakdown of current recommendations for Protech Home Medical and Smith & Nephew, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Protech Home Medical0000N/A
Smith & Nephew0000N/A

Profitability

This table compares Protech Home Medical and Smith & Nephew's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Protech Home MedicalN/AN/AN/A
Smith & NephewN/AN/AN/A

Summary

Protech Home Medical beats Smith & Nephew on 1 of the 1 factors compared between the two stocks.

Helius Medical Technologies (TSE:HSM) and Smith & Nephew (CNSX:SNN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability.

Profitability

This table compares Helius Medical Technologies and Smith & Nephew's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Helius Medical TechnologiesN/AN/AN/A
Smith & NephewN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations for Helius Medical Technologies and Smith & Nephew, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Helius Medical Technologies0000N/A
Smith & Nephew0000N/A

Earnings and Valuation

This table compares Helius Medical Technologies and Smith & Nephew's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helius Medical TechnologiesC$661,000.0075.63$-34,151,124.70C($14.78)-1.46
Smith & NephewN/AN/AN/AN/AN/A

Smith & Nephew has lower revenue, but higher earnings than Helius Medical Technologies.

Summary

Helius Medical Technologies beats Smith & Nephew on 1 of the 1 factors compared between the two stocks.


Smith & Nephew Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
VMD
Viemed Healthcare
0.3$11.73flatC$464.06 millionC$131.31 million12.02
TMD
Titan Medical
0.8$1.98flatC$216.86 millionC$20 million-4.38Analyst Report
News Coverage
Hamilton Thorne logo
HTL
Hamilton Thorne
1.2$1.74flatC$165.83 millionC$39.78 million193.33
Protech Home Medical logo
PTQ
Protech Home Medical
1.2$2.15flatC$94.56 millionC$82.22 million-44.79
PHM
Protech Home Medical
0.5$0.12flatC$50.12 millionC$77.14 million57.50Gap Up
HSM
Helius Medical Technologies
0.5$21.63flatC$49.99 millionC$661,000.00-1.46
ASG
Aurora Spine
0.6$0.79flatC$8.31 millionC$8.84 million-41.58Gap Up
BLO
Cannabix Technologies
0.5N/AN/AC$0.00N/A0.00Gap Up
ORTH
Ortho Regenerative Technologies
0.5N/AN/A$0.00N/A0.00High Trading Volume
VMD
Viemed Healthcare
0.5$4.95flatC$0.00N/A0.00Gap Up
This page was last updated on 4/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.